Skip to main content

Table 1 Clinical and laboratory characteristics of the study group at the time of liver biopsy

From: Comparative study between liver biopsy and non-invasive biomarkers in assessment of hepatic fibrosis in children with chronic liver diseases

Variable Hepatic patients (N = 200)
Age (years) 6.3 ± 3.8 (2–15)
Sex Male 98 (49%)
Female 102 (51%)
Weight (kg)
Centiles
18.2 ± 5.9 (9.0–40.0)
(5th–75th)
Height (cm)
Centiles
95.4 ± 32.4 (70.0–149.0)
(<3rd–85th)
BMI (kg/m2)
Centiles
19.3 ± 7.3 (13.0–50.7)
(0.1th–95th)
BMI z-score 0.13 ± 2.9 (−4.8:6.0)
AST (IU/L) 142.8 ± 198.8 (20–1080)
ALT (IU/L) 155.7 ± 205.8 (18–1170)
T. bilirubin (mg/dL) 4.5 ± 5.03 (0.2–21.0)
D. bilirubin (mg/dL) 2.6 ± 3.1 (0.1–13.0)
ALP (IU/L) 520.6 ± 493 (80–1192)
GGT (IU/L) 73.7 ± 119.5 (41–668)
Hb (g/dL) 9.6 ± 1.7 (8.5–11.0)
PLTs (103/μL ) 246.5 ± 137.9 (150.0–435.0)
  1. Data expressed as mean ± SD (range). BMI body mass index, AST aspartate aminotransferase, ALT alanine transaminase, T. bilirubin total bilirubin, D. bilirubin direct bilirubin, ALP alkaline phosphatase, GGT gamma-glutamyl transferase, Hb hemoglobin, PLTs platelets